CRISPR-powered 'cancer shredding' technique opens new possibility for treating most common and deadly brain cancer
The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to findings of a new study from Gladstone Institutes.
Nov 27, 2023
2
37
